Titan Pharmaceuticals
TTNP
#10396
Rank
โ‚น0.56 B
Marketcap
โ‚น422.47
Share price
-3.76%
Change (1 day)
50.18%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น402.30. In 2023 the company made an earnings per share (EPS) of -โ‚น679.06 an increase over its 2022 EPS that were of -โ‚น1,392.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น679.06-51.22%
2022-โ‚น1,392-15.61%
2021-โ‚น1,650-81.37%
2020-โ‚น8,853-77.52%
2019-โ‚น39,387-56.32%
2018-โ‚น90,176-59.51%
2017-โ‚น2,22,734-371.81%
2016โ‚น81,944-144.35%
2015-โ‚น1,84,750300%
2014-โ‚น46,187-121.54%
2013โ‚น2,14,442-151.38%
2012-โ‚น4,17,337-11.54%
2011-โ‚น4,71,772188.89%
2010-โ‚น1,63,306-10%
2009-โ‚น1,81,451
2007-โ‚น7,43,948-2.38%
2006-โ‚น7,62,093-39.13%
2005-โ‚น12,52,011-16.87%
2004-โ‚น15,06,042-22.43%
2003-โ‚น19,41,5244.9%
2002-โ‚น18,50,79861.9%
2001-โ‚น11,43,140-13.7%
2000-โ‚น13,24,59165.01%
1999-โ‚น8,02,747-35.87%
1998-โ‚น12,51,797-1824.71%
1997โ‚น72,580-102.4%
1996-โ‚น30,30,229

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น956.68-337.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น674.48-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น130.13-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น2.75-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น22.91-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น309.75-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA